Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease.
about
A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzymeGenetic risk factors and restenosis after percutaneous coronary interventions.The DD-ACE genotype and cardiovascular disease.Genetic variation in coronary heart disease and myocardial infarction: methodological overview and clinical evidence.Association between angiotensin I-converting enzyme gene polymorphism and susceptibility to cancer: a meta analysisApplication of industrial scale genomics to discovery of therapeutic targets in heart failure.Angiotensin-converting enzyme gene polymorphism and allele frequencies in the Lebanese population: prevalence and review of the literature.Pharmacogenetics in heart failure: genomic markers of endothelial and neurohumoral function.Genomic variation and neurohormonal intervention in heart failure.Heart failure pharmacogenetics: past, present, and future.Genetics of coronary artery disease and myocardial infarction--2013.Pharmacogenetics and interstitial lung disease.Insertion/Insertion Genotype of Angiotensin I-Converting-Enzyme Gene Predicts Risk of Myocardial Infarction in North East India.Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes.Progression of Left Ventricular Dysfunction and Remodelling under Optimal Medical Therapy in CHF Patients: Role of Individual Genetic Background.Pharmacogenomics in heart failure: individualizing therapy based on genotype.Pharmacogenetics in cardiovascular disease: the challenge of moving from promise to realization: concepts discussed at the Canadian Network and Centre for Trials Internationally Network Conference (CANNeCTIN), June 2009.An angiotensin converting enzyme haplotype predicts survival in patients with end stage renal disease.Impact of I/D polymorphism of angiotensin-converting enzyme (ACE) gene on myocardial infarction susceptibility among young Moroccan patients.Overestimation of genetic risks owing to small sample sizes in cardiovascular studies.Genotype combinations of plasminogen activator inhibitor-1 and angiotensin-converting enzyme genes and risk for early onset of coronary heart disease.No association between ACE polymorphism and risk of nasopharyngeal carcinoma.
P2860
Q24306614-6BAF5C7B-6F60-42AB-89DA-ED32A8B15BC8Q33860926-7C422F91-9645-4C83-BA8B-3EDA70657E7BQ34188516-4A7AF7DB-536E-41E6-9782-B06C80EC7027Q34189907-BC6ABFA6-C5CB-47FB-AC40-0746A4C73995Q34371778-1BA6B5D1-DA63-4B41-9A03-2B5BD494FD81Q34459962-C18EB7DD-00EA-414F-8322-BACB5CD7E12AQ34581489-9974D85F-5865-4013-B910-1AA900930146Q35980619-9CE4A80E-AE74-4F1E-B699-A9BE4E9B9FB2Q36170188-AA9063C4-27D5-4B02-9933-8A3E2D6A6D52Q37854508-6F6BFDF3-5F85-4721-B1DA-08A210FACD6CQ38101513-EABA51BA-13D4-48C2-9DAA-22F633BCDAA6Q38851479-BDA76192-A1DF-4E28-885C-6C63659BEB73Q41034741-AC3CAE45-B3D4-45EC-A47F-E41895DB7B83Q41840991-CFF34900-6FB0-4412-AD6B-CFFF95142169Q42114659-D940C614-BF35-4A8F-9D0B-A9E5FD1D38AEQ44681090-37E6273D-1140-4D92-BB54-B16414722343Q45337198-55BC9DE8-0F6C-4814-A695-AA16D1ECF65CQ46894502-8B72B0BF-78D2-4D53-91FE-17AB43406291Q49205493-0CE57A9B-5CF1-435A-BD20-4EF866E4D7E5Q52951935-B6E3E98D-0D59-4941-AFDD-D4E1E24CAB85Q53250994-EE0CE53D-DD73-4CBA-BA9A-4550F3168A83Q54340399-766A65BA-3ABB-4F51-9631-B10609B934A4
P2860
Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Deletion polymorphism of the a ...... n and coronary artery disease.
@en
Deletion polymorphism of the a ...... n and coronary artery disease.
@nl
type
label
Deletion polymorphism of the a ...... n and coronary artery disease.
@en
Deletion polymorphism of the a ...... n and coronary artery disease.
@nl
prefLabel
Deletion polymorphism of the a ...... n and coronary artery disease.
@en
Deletion polymorphism of the a ...... n and coronary artery disease.
@nl
P2093
P1476
Deletion polymorphism of the a ...... n and coronary artery disease.
@en
P2093
Siekmeier R
Winkelmann BR
P356
10.7326/0003-4819-125-1-199607010-00004
P407
P577
1996-07-01T00:00:00Z